ProQR Therapeutics N.V.
(NASDAQ : PRQR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
0.63%105.161.1%$1250.41m
GILDGilead Sciences, Inc.
0.43%72.820.9%$635.59m
AMGNAmgen Inc.
0.07%169.961.1%$483.52m
BIIBBiogen Inc.
0.24%309.801.2%$426.39m
REGNRegeneron Pharmaceuticals, Inc.
0.81%387.542.7%$354.48m
ALXNAlexion Pharmaceuticals, Inc.
-0.42%107.601.9%$279.93m
VRTXVertex Pharmaceuticals Incorporated
1.33%147.041.9%$234.21m
ALNYAlnylam Pharmaceuticals, Inc
0.24%132.3310.0%$190.13m
INCYIncyte Corporation
0.05%99.002.5%$178.71m
NKTRNektar Therapeutics
-0.46%49.756.1%$170.43m
ILMNIllumina, Inc.
1.56%215.353.5%$165.34m
JUNOJuno Therapeutics, Inc.
2.65%60.3313.5%$136.10m
AAgilent Technologies, Inc.
-1.75%68.691.5%$131.83m
SRPTSarepta Therapeutics, Inc.
0.66%56.2216.8%$117.39m
BLUEBluebird Bio, Inc.
-0.03%167.2017.2%$114.30m

Company Profile

ProQR Therapeutics NV operates as a biopharmaceutical company, which engages in the discovery and development of Ribonucleic Acid RNA based therapeutics for the treatment of genetic disorders. Its initial focus is on the development of a disease-modifying therapy for the treatment of cystic fibrosis. The company was founded by Daniel de Boer, Gerard Platenburg, Henri Termeer and Dinko Valerio on February 21, 2012 and is headquartered in Leiden, the Netherlands.